Javascript must be enabled to continue!
Abstract 2618: IQGAP3 regulates intra-cellular Ras signaling and intra-tumoral malignant cycles via TGFβ signaling
View through CrossRef
Abstract
Scaffold protein IQ motif-containing GTPase-activating protein 3 (IQGAP3; IQ3) is a member of the multifunctional IQGAP family. The interaction between IQ3 and Ras-ERK signaling has been reported, but how IQ3 regulates Ras-ERK signaling in malignancies is still unclear. The purpose of this study is to elucidate the role of IQ3 in coordinating diverse pathways, such as ERK-Ras and TGFβ in gastric cancer (GC).According to Stomach Adenocarcinoma of TCGA Pan-Cancer Atlas, the frequency of gene mutations is high in TP53 (60.1%), RTK-Ras (51.8%), and TGFβ pathways (36.4%). Gene Set Enrichment Analysis (GSEA) indicated that KRAS signaling was significantly downregulated after IQ3 knockdown (KD) in three GC cell lines (AGS, NUGC3, Hs746T). Ingenuity upstream regulator analysis (IPA) of RNA sequencing data revealed that TGFβ1, the top-ranked growth factor, is significantly inhibited after IQ3 KD. Immunoblot analysis showed that IQ3 KD led to suppression of TGFβ-induced phosphorylation of MEK/ERK in three GC cell lines, particularly NUGC3. While TGFβ treatment promoted invasion and migration in transwell migration assays, IQ3 KD significantly diminished TGFβ-mediated cell migration. In vivo, the size and volume of subcutaneous tumors from IQ3 KD NUGC3 cells were significantly smaller than that from Control (Ctrl) cells. According to RNA sequencing using bulk tumors, mouse stromal cells in Ctrl tumors showed significantly higher expression of acta2, fap, pdgfa, which are the markers of cancer-associated fibroblasts, than in IQ3 KD tumors. The TGFβ1 expression levels in the NUGC3 xenograft and mouse stromal cells harvested from Ctrl were significantly higher than that from IQ3 KD, respectively. Additionally, digital spatial profiler (DSP) GeoMx evaluation of the intra-tumoral expressions from the human xenograft and mouse stromal cells showed that the mouse stromal cells from Ctrl expressed significantly higher acta2 and tgfβ1 than that from IQ3 KD. Furthermore, metastasis assays via tail vein injection in vivo showed dramatically lesser lung metastases from IQ3 KD cells than that from Ctrl cells. This study shows that IQ3 KD suppressed Ras signaling and blocked upstream regulator TGFβ1 in vitro. The stromal cells in the IQ3 KD xenografts showed a reduced population of cancer-associated fibroblasts in vivo. Consequently, tumorigenesis and metastasis were strongly suppressed after IQ3 KD. IQ3 is thus a highly relevant therapy target in GC.
Citation Format: Mitsuhiro Shimura, Pang SHUCHIN, Junichi Matsuo, Linda Shyue Chuang, Yoshiaki Ito. IQGAP3 regulates intra-cellular Ras signaling and intra-tumoral malignant cycles via TGFβ signaling [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2618.
American Association for Cancer Research (AACR)
Title: Abstract 2618: IQGAP3 regulates intra-cellular Ras signaling and intra-tumoral malignant cycles via TGFβ signaling
Description:
Abstract
Scaffold protein IQ motif-containing GTPase-activating protein 3 (IQGAP3; IQ3) is a member of the multifunctional IQGAP family.
The interaction between IQ3 and Ras-ERK signaling has been reported, but how IQ3 regulates Ras-ERK signaling in malignancies is still unclear.
The purpose of this study is to elucidate the role of IQ3 in coordinating diverse pathways, such as ERK-Ras and TGFβ in gastric cancer (GC).
According to Stomach Adenocarcinoma of TCGA Pan-Cancer Atlas, the frequency of gene mutations is high in TP53 (60.
1%), RTK-Ras (51.
8%), and TGFβ pathways (36.
4%).
Gene Set Enrichment Analysis (GSEA) indicated that KRAS signaling was significantly downregulated after IQ3 knockdown (KD) in three GC cell lines (AGS, NUGC3, Hs746T).
Ingenuity upstream regulator analysis (IPA) of RNA sequencing data revealed that TGFβ1, the top-ranked growth factor, is significantly inhibited after IQ3 KD.
Immunoblot analysis showed that IQ3 KD led to suppression of TGFβ-induced phosphorylation of MEK/ERK in three GC cell lines, particularly NUGC3.
While TGFβ treatment promoted invasion and migration in transwell migration assays, IQ3 KD significantly diminished TGFβ-mediated cell migration.
In vivo, the size and volume of subcutaneous tumors from IQ3 KD NUGC3 cells were significantly smaller than that from Control (Ctrl) cells.
According to RNA sequencing using bulk tumors, mouse stromal cells in Ctrl tumors showed significantly higher expression of acta2, fap, pdgfa, which are the markers of cancer-associated fibroblasts, than in IQ3 KD tumors.
The TGFβ1 expression levels in the NUGC3 xenograft and mouse stromal cells harvested from Ctrl were significantly higher than that from IQ3 KD, respectively.
Additionally, digital spatial profiler (DSP) GeoMx evaluation of the intra-tumoral expressions from the human xenograft and mouse stromal cells showed that the mouse stromal cells from Ctrl expressed significantly higher acta2 and tgfβ1 than that from IQ3 KD.
Furthermore, metastasis assays via tail vein injection in vivo showed dramatically lesser lung metastases from IQ3 KD cells than that from Ctrl cells.
This study shows that IQ3 KD suppressed Ras signaling and blocked upstream regulator TGFβ1 in vitro.
The stromal cells in the IQ3 KD xenografts showed a reduced population of cancer-associated fibroblasts in vivo.
Consequently, tumorigenesis and metastasis were strongly suppressed after IQ3 KD.
IQ3 is thus a highly relevant therapy target in GC.
Citation Format: Mitsuhiro Shimura, Pang SHUCHIN, Junichi Matsuo, Linda Shyue Chuang, Yoshiaki Ito.
IQGAP3 regulates intra-cellular Ras signaling and intra-tumoral malignant cycles via TGFβ signaling [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL.
Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2618.
Related Results
CLIMATE-2019 Program committee
CLIMATE-2019 Program committee
NOTITLE. Chairman
Mokhov Igor
RAS academecian, Dr. Sci., Professor
...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Study on Strengthening and Toughening Mechanisms of Aluminum Alloy 2618-Ti at Elevated Temperature
Study on Strengthening and Toughening Mechanisms of Aluminum Alloy 2618-Ti at Elevated Temperature
AbstractThe tensile properties of the alloy 2618 and 2618-Ti were tested using a tensile testing machine. The morphologies of the fracture of tensile samples were observed using sc...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Abstract A31: Targeting Oncogenic Ras Activation for Cancer Prevention
Abstract A31: Targeting Oncogenic Ras Activation for Cancer Prevention
Abstract
Increased Ras activity levels due to active mutations of Ras are critical for tumorigenesis. These oncogenic Ras mutations are considered to be locked in a ...
Abstract 5095: The Role of Circulating Transforming Growth Factor-β in Vascular Ehlers-Danlos Syndrome: Implications for Drug Therapy
Abstract 5095: The Role of Circulating Transforming Growth Factor-β in Vascular Ehlers-Danlos Syndrome: Implications for Drug Therapy
Objective: TGFβ signaling has been shown to play a major role in the pathogenesis of Marfan syndrome (MFS), leading to a novel treatment strategy through TGFβ inhibition using losa...
Targeting TGFβ signal transduction for cancer therapy
Targeting TGFβ signal transduction for cancer therapy
AbstractTransforming growth factor-β (TGFβ) family members are structurally and functionally related cytokines that have diverse effects on the regulation of cell fate during embry...
Abstract 1087: NF1 regulates the RAS-related GTPases, RRAS and RRAS2, independent of RAS activity
Abstract 1087: NF1 regulates the RAS-related GTPases, RRAS and RRAS2, independent of RAS activity
Abstract
Neurofibromin, which is encoded by the neurofibromatosis type 1 (NF1) gene, is a tumor suppressor that acts as a RAS-GTPase activating protein (RAS-GAP) to ...

